Security key
12529R107
C4 Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CCCC)
CUSIP: 12529R107
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 35,893,940
- Total 13F value
- $1,154,835,979
- Share change
- +688,260
- SEC-reported price per share
- $32.20
- Number of holders
- 115
- Value change
- +$16,687,200
- Number of buys
- 55
- Number of sells
- 47
- Shares outstanding
- 111,000,000
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
115
Top holders
10
CCCC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
C4 Therapeutics, Inc. SEC filings
C4 Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 12529R107
Recent filing periods:
Ownership snapshot
Top reported holders of CCCC - C4 Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 3.6%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 3.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
3.6%
BlackRock Finance, Inc.
2.8%
RTW INVESTMENTS, LP
2.2%
PERCEPTIVE ADVISORS LLC
2%
VANGUARD GROUP INC
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
3.6%
|
$176,832,000
3,957,743 shares
|
— | 30 Sep 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
2.8%
|
$141,064,000
3,157,207 shares
|
— | 30 Sep 2021 |
| RTW INVESTMENTS, LP |
13F
Company
|
2.2%
|
$111,475,000
2,494,965 shares
|
— | 30 Sep 2021 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
2%
|
$100,913,000
2,258,566 shares
|
— | 30 Sep 2021 |
| VANGUARD GROUP INC |
13F
Company
|
1.7%
|
$86,616,000
1,938,575 shares
|
— | 30 Sep 2021 |
| STATE STREET CORP |
13F
Company
|
1.5%
|
$74,108,000
1,658,630 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
115
Shares
35,893,940
Rows available
115
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
110
Q4 2021 holders
115
Holder diff
5
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend